Hugely popular weight-loss jabs like Wegovy have been making headlines for enabling people to manage diabetes and excess weight along with other benefits, scientists say.Increasingly recommended by ...

Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal ...

Losing excess weight would in turn improve health. For example, lower levels of sleep apnoea – when breathing stops and ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...